REBINYN is a Kit in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is .
Product ID | 0169-7902_2df3f725-b51f-4984-976f-e3069d69210f |
NDC | 0169-7902 |
Product Type | Human Prescription Drug |
Proprietary Name | REBINYN |
Generic Name | (coagulation Factor Ix (recombinant), Glycopegylated) |
Dosage Form | Kit |
Marketing Start Date | 2017-12-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125611 |
Labeler Name | Novo Nordisk |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2017-12-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125611 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-12-01 |
SPL SET ID: | 0ea37235-35fd-410d-b8c4-40ba15fe1294 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0169-7901 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
0169-7902 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
0169-7903 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
0169-7905 | REBINYN | (Coagulation Factor IX (Recombinant), GlycoPEGylated) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REBINYN 79156280 4714544 Live/Registered |
Novo Nordisk Health Care AG 2014-07-14 |